These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 34292652)
1. miR-671-5p repressed progression of papillary thyroid carcinoma via TRIM14. Wang WJ; Yuan Y; Zhang D; Liu P; Liu F Kaohsiung J Med Sci; 2021 Nov; 37(11):983-990. PubMed ID: 34292652 [TBL] [Abstract][Full Text] [Related]
2. Circ_RPPH1 facilitates progression of breast cancer via miR-1296-5p/TRIM14 axis. Jiang J; Shi S; Zhang W; Li C; Sun L; Ge Q; Li X Cancer Biol Ther; 2024 Dec; 25(1):2360768. PubMed ID: 38816350 [No Abstract] [Full Text] [Related]
3. miR-4443 targets TRIM14 to suppress metastasis and energy metabolism of papillary thyroid carcinoma (PTC) in vitro. Zuo XM; Sun HW; Fang H; Wu Y; Shi Q; Yu YF Cell Biol Int; 2021 Sep; 45(9):1917-1925. PubMed ID: 34051007 [TBL] [Abstract][Full Text] [Related]
4. Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis. Xie F; Xiong Y; Yan J; Wang L; Yan W Bioengineered; 2022 Feb; 13(2):1963-1974. PubMed ID: 34787066 [TBL] [Abstract][Full Text] [Related]
5. miR-199a-5p inhibits the progression of papillary thyroid carcinoma by targeting SNAI1. Ma S; Jia W; Ni S Biochem Biophys Res Commun; 2018 Feb; 497(1):181-186. PubMed ID: 29427661 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-524-5p suppresses the progression of papillary thyroid carcinoma cells via targeting on FOXE1 and ITGA3 in cell autophagy and cycling pathways. Liu H; Chen X; Lin T; Chen X; Yan J; Jiang S J Cell Physiol; 2019 Aug; 234(10):18382-18391. PubMed ID: 30941771 [TBL] [Abstract][Full Text] [Related]
7. Human mesenchymal stem cells derived exosomes inhibit the growth of acute myeloid leukemia cells via regulating miR-23b-5p/TRIM14 pathway. Cheng H; Ding J; Tang G; Huang A; Gao L; Yang J; Chen L Mol Med; 2021 Oct; 27(1):128. PubMed ID: 34656078 [TBL] [Abstract][Full Text] [Related]
8. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis. Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833 [TBL] [Abstract][Full Text] [Related]
9. LINC00958/miR-627 signal axis regulates the proliferation, migration, and invasion of thyroid papillary carcinoma cells by TRIM44. Li YQ; Wang LC; Li AX; Huang W; Song Y; Wang W Kaohsiung J Med Sci; 2022 May; 38(5):415-424. PubMed ID: 35199939 [TBL] [Abstract][Full Text] [Related]
10. LncRNA PTCSC3/miR-574-5p Governs Cell Proliferation and Migration of Papillary Thyroid Carcinoma via Wnt/β-Catenin Signaling. Wang X; Lu X; Geng Z; Yang G; Shi Y J Cell Biochem; 2017 Dec; 118(12):4745-4752. PubMed ID: 28513866 [TBL] [Abstract][Full Text] [Related]
11. m Wu X; Fu M; Ge C; Zhou H; Huang H; Zhong M; Zhang M; Xu H; Zhu G; Hua W; Lv K; Yang H Mol Neurobiol; 2024 Aug; 61(8):5418-5440. PubMed ID: 38193984 [TBL] [Abstract][Full Text] [Related]
12. MiR-204-5p suppresses cell proliferation by inhibiting IGFBP5 in papillary thyroid carcinoma. Liu L; Wang J; Li X; Ma J; Shi C; Zhu H; Xi Q; Zhang J; Zhao X; Gu M Biochem Biophys Res Commun; 2015 Feb; 457(4):621-6. PubMed ID: 25603050 [TBL] [Abstract][Full Text] [Related]
13. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
14. miR-335-5p targeting ICAM-1 inhibits invasion and metastasis of thyroid cancer cells. Luo L; Xia L; Zha B; Zuo C; Deng D; Chen M; Hu L; He Y; Dai F; Wu J; Wang C; Wang Y; Zhang Q Biomed Pharmacother; 2018 Oct; 106():983-990. PubMed ID: 30119270 [TBL] [Abstract][Full Text] [Related]
15. miR-195-5p Suppresses the Proliferation, Migration, and Invasion of Oral Squamous Cell Carcinoma by Targeting TRIM14. Wang T; Ren Y; Liu R; Ma J; Shi Y; Zhang L; Bu R Biomed Res Int; 2017; 2017():7378148. PubMed ID: 29204446 [TBL] [Abstract][Full Text] [Related]
16. MiR-20b Displays Tumor-Suppressor Functions in Papillary Thyroid Carcinoma by Regulating the MAPK/ERK Signaling Pathway. Hong S; Yu S; Li J; Yin Y; Liu Y; Zhang Q; Guan H; Li Y; Xiao H Thyroid; 2016 Dec; 26(12):1733-1743. PubMed ID: 27717302 [TBL] [Abstract][Full Text] [Related]
17. miR-219-5p modulates cell growth of papillary thyroid carcinoma by targeting estrogen receptor α. Huang C; Cai Z; Huang M; Mao C; Zhang Q; Lin Y; Zhang X; Tang B; Chen Y; Wang X; Qian Z; Ye L; Peng Y; Xu H J Clin Endocrinol Metab; 2015 Feb; 100(2):E204-13. PubMed ID: 25423566 [TBL] [Abstract][Full Text] [Related]
18. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells. Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911 [TBL] [Abstract][Full Text] [Related]
19. LncRNA TNRC6C-AS1 regulates UNC5B in thyroid cancer to influence cell proliferation, migration, and invasion as a competing endogenous RNA of miR-129-5p. Hou S; Lin Q; Guan F; Lin C J Cell Biochem; 2018 Nov; 119(10):8304-8316. PubMed ID: 29893424 [TBL] [Abstract][Full Text] [Related]
20. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. Ma X; Wei J; Zhang L; Deng D; Liu L; Mei X; He X; Tian J Biomed Pharmacother; 2016 May; 80():220-226. PubMed ID: 27133060 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]